Help us improve Portfolio Grader.

Help us improve Portfolio Grader.

Blue Chip Growth

Stock Report: Leucadia National Corporation (LUK) Report Updated: Feb 08, 2016 | Print This Page

Get more stock ratings by Louis Navellier

Leucadia National Corporation (LUK)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Diversified Financial Services
Competitors: AMRK, MKTX, NDAQ, MSCI
service keys

Leucadia National Corporation© quotemedia

Company Profile

Leucadia National Corporation engages in beef processing, manufacturing, land based contract oil and gas drilling, gaming entertainment, real estate activities, medical product development, and winery operations in the United States and internationally. It processes, packages, and delivers boxed beef, ground beef, hides, tallow, and other beef and beef by-products. The company is also involved in remanufacturing, manufacturing, and/or distributing dimension lumber, home center boards for retailers, pine decking, and other specialty wood products; and manufacturing and marketing lightweight plastic netting used in building and construction, erosion control, packaging, agricultural, carpet padding, filtration, and consumer products. Its land based contract oil and gas drilling operations include the provision of drilling services through 26 drilling rigs to independent oil and natural gas exploration and production companies in the Mid-Continent region of the United States. The company’s gaming entertainment operations consist of owning the Hard Rock Hotel & Casino Biloxi located in Biloxi, Mississippi, which includes 325 rooms and suites, 1,305 slot machines, 52 table games, 6 live poker tables, 5 restaurants, and a spa. Its real estate activities include investment in commercial properties, residential land development projects, and other unimproved land. The company’s medical product development operations comprise the development of MP4OX that has completed a Phase II proof of concept clinical trial and is a solution of cell-free hemoglobin, administered intravenously to provide oxygen delivery to ischemic tissues; and MP4CO, a product in Phase Ib clinical study to treat sickle cell disease patients. In addition, it engages in the production and sale of wines; and investment and evaluation of gasification projects to convert various types of low grade fossil fuels into energy products. The company was founded in 1854 and is based in New York, New York.

Recent News: Leucadia National Corporation